Search research articles
Contact Us
Filters
Showing results (301-310 of 349) with videos related to
Page
of 35
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
June 5, 2023
Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors
Hirono Tsutsumi, Hiroyuki Inoue, Yoshimasa Shiraishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 18, 2026
Impact of Etiological Shifts and the Rising Burden of Non-B Non-C Hepatocellular Carcinoma on Surveillance and Prognosis: Insights From a 20-Year Retrospective Observational Study
Yoko Yoshimaru, Katsuya Nagaoka, Hiroko Setoyama, et al.
Journal of Cancer Research and Clinical Oncology
|
October 28, 2022
Reliability, validity, and responsiveness of the Japanese version of the EORTC QLQ-ELD14 in evaluating the health-related quality of life of elderly patients with cancer
Yumiko Kinoshita, Rieko Izukura, Junji Kishimoto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2023
Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study
Ryota Saito, Shunichi Sugawara, Ryo Ko, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 23, 2025
A treatment-related death predictive score for treatment-naïve advanced non-small cell lung cancer
Shogo Nomura, Yuta Sekino, Yoshimasa Shiraishi, et al.
Cancer Treatment and Research Communications
|
October 2, 2025
Study protocol of an open-label prospective phase II study of Durvalumab plus Carboplatin and Etoposide in advanced large cell neuroendocrine carcinoma of the lung (LOGIK2401: NECTAR study)
Hidenobu Ishii, Koichi Azuma, Fumiaki Kiyomi, et al.
Scientific Reports
|
July 29, 2022
Upregulation of the hypothalamo-neurohypophysial system and activation of vasopressin neurones attenuates hyperalgesia in a neuropathic pain model rat
Kazuhiko Baba, Makoto Kawasaki, Haruki Nishimura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 9, 2025
Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)
Taiki Hakozaki, Kentaro Tanaka, Yoshimasa Shiraishi, et al.
Neuroscience Research
|
January 13, 2021
Heat hypersensitivity is attenuated with altered expression level of spinal astrocytes after sciatic nerve injury in TRPV1 knockout mice
Kazuhiko Baba, Makoto Kawasaki, Haruki Nishimura, et al.
International Journal of Clinical Oncology
|
February 5, 2025
Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study
Katsuyuki Hotta, Sho Saeki, Shinya Sakata, et al.
Page
of 35
Search research articles
Search
Showing results (301-310 of 349) with videos related to
Sort By:
Page
of 35
Lung Cancer (Amsterdam, Netherlands)
|
June 5, 2023
Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors
Hirono Tsutsumi, Hiroyuki Inoue, Yoshimasa Shiraishi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 18, 2026
Impact of Etiological Shifts and the Rising Burden of Non-B Non-C Hepatocellular Carcinoma on Surveillance and Prognosis: Insights From a 20-Year Retrospective Observational Study
Yoko Yoshimaru, Katsuya Nagaoka, Hiroko Setoyama, et al.
Journal of Cancer Research and Clinical Oncology
|
October 28, 2022
Reliability, validity, and responsiveness of the Japanese version of the EORTC QLQ-ELD14 in evaluating the health-related quality of life of elderly patients with cancer
Yumiko Kinoshita, Rieko Izukura, Junji Kishimoto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2023
Phase 2 study of osimertinib in combination with platinum and pemetrexed in patients with previously untreated EGFR-mutated advanced non-squamous non-small cell lung cancer: The OPAL Study
Ryota Saito, Shunichi Sugawara, Ryo Ko, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 23, 2025
A treatment-related death predictive score for treatment-naïve advanced non-small cell lung cancer
Shogo Nomura, Yuta Sekino, Yoshimasa Shiraishi, et al.
Cancer Treatment and Research Communications
|
October 2, 2025
Study protocol of an open-label prospective phase II study of Durvalumab plus Carboplatin and Etoposide in advanced large cell neuroendocrine carcinoma of the lung (LOGIK2401: NECTAR study)
Hidenobu Ishii, Koichi Azuma, Fumiaki Kiyomi, et al.
Scientific Reports
|
July 29, 2022
Upregulation of the hypothalamo-neurohypophysial system and activation of vasopressin neurones attenuates hyperalgesia in a neuropathic pain model rat
Kazuhiko Baba, Makoto Kawasaki, Haruki Nishimura, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 9, 2025
Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON)
Taiki Hakozaki, Kentaro Tanaka, Yoshimasa Shiraishi, et al.
Neuroscience Research
|
January 13, 2021
Heat hypersensitivity is attenuated with altered expression level of spinal astrocytes after sciatic nerve injury in TRPV1 knockout mice
Kazuhiko Baba, Makoto Kawasaki, Haruki Nishimura, et al.
International Journal of Clinical Oncology
|
February 5, 2025
Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study
Katsuyuki Hotta, Sho Saeki, Shinya Sakata, et al.
Page
of 35